Literature DB >> 2192446

Paramedian versus midline incision for the insertion of permanent peritoneal dialysis catheters. A randomized clinical trial.

E Ejlersen1, K Steven, H Løkkegaard.   

Abstract

A randomized trial was conducted to examine the influence of the site of catheter insertion on the mechanical complications associated with the use of peritoneal dialysis catheters (pericatheter leakage/herniation and tip migration). 37 patients requiring a dialysis catheter for future CAPD were randomized to insertion by either a midline (prior standard approach) or a lateral incision (new approach). Thirteen catheters (6 midline, 7 lateral) failed for mechanical reasons--mainly irreversible tip migration. The one year estimated catheter survival without mechanical failure was found to be similar in the two groups: midline (59%) and lateral (51%), (0.4 less than p less than 0.5).

Entities:  

Mesh:

Year:  1990        PMID: 2192446     DOI: 10.3109/00365599009180383

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  3 in total

1.  Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients.

Authors:  Htay Htay; David W Johnson; Jonathan C Craig; Francesco Paolo Schena; Giovanni Fm Strippoli; Allison Tong; Yeoungjee Cho
Journal:  Cochrane Database Syst Rev       Date:  2019-05-31

2.  Peritoneal Dialysis for Acute Kidney Injury Treatment in the United States: Brought to You by the COVID-19 Pandemic.

Authors:  Vesh Srivatana; Vikram Aggarwal; Fredric O Finkelstein; Mihran Naljayan; John H Crabtree; Jeffrey Perl
Journal:  Kidney360       Date:  2020-04-24

Review 3.  ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Javier de Arteaga; Stanley Fan; Ana E Figueiredo; Douglas N Fish; Eric Goffin; Yong-Lim Kim; William Salzer; Dirk G Struijk; Isaac Teitelbaum; David W Johnson
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.